FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025

Sep 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-08-31

Reporting Person: Raykov Rosty (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-31	Common shares	A	5208	—	Acquired	61086	Direct

Footnotes

F1: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.